Cardiovascular implications of modern algorithm of hypoglycemic therapy: ?Florentine hypothesis?

Código QR

Cardiovascular implications of modern algorithm of hypoglycemic therapy: ?Florentine hypothesis?

The modern algorithm of hypoglycemic therapy for patients with type 2 diabetes mellitus (DM2) has been designed to effectively reach the ?target?blood glucose and HbA1c levels associated with the lowest mortality rate.The most popular scheme is combined treatment with metformin andsulfonylureasthatm...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Andrey Alexeevich Aleksandrov, Svetlana Semenovna Kukharenko, Maria Nikolaevna Yadrikhinskaya
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2010
Materias:	type 2 diabetes mellitus algorithm of hypoglycemic therapy cardiovascular complications Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/0ef17485173f4d6dba361fd590ee9427
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Statins and diabetes mellitus: price of collaboration
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2012)

Pharmacogenetics of hypoglycemic agents
por: Irina Vladimirovna Kononenko, et al.
Publicado: (2015)

Atrial fibrillation: a new facet of diabetes mellitus in the XXI century
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2011)

Hypoglycemic therapy in patients on hemodialysis and peritoneal dialysis
por: Irina Arkad'evna Bondar', et al.
Publicado: (2010)

Barriers for efficacious hypoglycemic therapy in clinical practice (results of the Dialogue study)
por: Irina Evgen'evna Sapozhnikova, et al.
Publicado: (2010)

Consensus statement by a panel of experts of the Russian Association of Endocrinologists (RAE) on initiation and intensificationof hypoglycemic therapy for type 2 diabetes mellitus
por: Ivan Ivanovich Dedov, et al.
Publicado: (2011)

Sakharnyy diabet i gormonal'naya enterologiya: put' v prekrasnoe daleko?
por: Andrey Alexeevich Aleksandrov
Publicado: (2011)

ACE inhibitors as a risk factor for hypoglycemia
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2011)

Second line therapy in type 2 diabetes: legacy effect activation
por: Ekaterina A. Shestakova
Publicado: (2017)

Influence of hyperinsulinemic – hypoglycemic clamp on induced platelet aggregation, activity of physiological anticoagulants and von Willebrand factor in patients with type I diabetes
por: Iwona R. Jarek-Martynowa, et al.
Publicado: (2018)

Sakharnyy diabet i ishemicheskaya bolezn' serdtsa: poiski resheniya
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2005)

Komentarii k stat'e ?Kardiovaskulyarnye narusheniya u detey pri sakharnom diabete?
por: Andrey Alexeevich Aleksandrov
Publicado: (2005)

Algorithms of Specialized Medical Care for Diabetes Mellitus Patients
por: Ivan Ivanovich Dedov, et al.
Publicado: (2011)

Drug-drug Interactions between Hypoglycemic and Non-hypoglycemic Medication in Diabetic Patients with Comorbidities in a Tertiary Care Center: A Descriptive Cross-sectional Study
por: Lujaw Ratna Tuladhar, et al.
Publicado: (2021)

Beta-adrenoblokatory pri serdechnoy nedostatochnosti u bol'nykh sakharnym diabetom 2 tipa: karvedilol i risk gipoglikemiy
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2008)

Risk factors for diabetic autonomic cardiovascular neuropathy in children and adolescents with type 1 diabetes mellitus
por: Maria Rustemovna Shaidullina, et al.
Publicado: (2013)

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2013)

Kommentarii kardiologa k rekomendatsiyam po sakharnomu diabetu, prediabetu i serdechno-sosudistym zabolevaniyam ESC-EASD 2007
por: Andrey Alexeevich Aleksandrov
Publicado: (2008)

Sakharnyy diabet i ishemicheskaya bolezn' serdtsa: zagadka sul'fanilamidov
por: Andrey Alexeevich Aleksandrov
Publicado: (2002)

Sakharosnizhayushchie sul'fanilamidy i ?ishemicheskiy porog? serdtsa u bol'nykh sakharnym diabetom tipa 2 s koronarnoy bolezn'yu serdtsa
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2002)

Epidemiology of acute diabetes complications (coma) according to the Federal Diabetes register of the Russian Federation (2013–2016)
por: Alexander Y. Mayorov, et al.
Publicado: (2018)

Time-Dependent Hypoglycemic and Hypolipidemic Effect of Allium Ascalonicum L. Feeding in Diabetic Rats
por: F Fallahi,, et al.
Publicado: (2010)

Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2013)

Problemy ostrogo infarkta miokarda u bol'nykh sakharnym diabetom: ekho Myunkhena
por: Ivan Ivanovich Dedov, et al.
Publicado: (2008)

Pharmacoeconomic simulation of delayed results of the treatment of type 2 diabetes mellitus with modern insulin analogsin comparison with oral hypoglycemic agents
por: Ivan Ivanovich Dedov, et al.
Publicado: (2010)

Hypoglycemic activity and constituents analysis of blueberry (Vaccinium corymbosum) fruit extracts
por: Huang W, et al.
Publicado: (2018)

Diabetes type 2 diabetes in the elderly – solved and unsolved questions
por: Tat'jana Vladimirovna Saprina, et al.
Publicado: (2016)

Problemy i perspektivy gipolipidemicheskoy terapii pri sakharnom diabete (Soobshchenie 1)
por: Ivan Ivanovich Dedov, et al.
Publicado: (2000)

The 3d World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension, Prague, 13-16 May 2010
por: Olga Konstantinovna Vikulova, et al.
Publicado: (2010)

Comparative pharmacoepidemiological study of antihyperglycemic drugs utilization by patients with type 2 diabetes mellitus in Moscow
por: Marina F. Kalashnikova, et al.
Publicado: (2016)

Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies
por: Marina V. Shestakova, et al.
Publicado: (2017)

Prevalence of combined atherosclerotic vascular lesions in patients with diabetes mellitus
por: Svetlana Alexandrovna Gracheva, et al.
Publicado: (2012)

Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV (6th edition)
por: Ivan Ivanovich Dedov, et al.
Publicado: (2013)

Age and sex-related variations in the time of manifestation of type 1 diabetes mellitus and its chronic complications in children
por: Oleg Avgustovich Dianov, et al.
Publicado: (2010)

Low risk of hypoglycemia and high efficacy of gliclazide MB: results of recent studies
por: I. V. Kononenko, et al.
Publicado: (2021)

Vildagliptin and its role in the treatment of diabetes mellitus
por: Yury Shavkatovich Khalimov
Publicado: (2010)

Issledovanie ADVANCE: vliyanie Noliprela - fiksirovannoy kombinatsii ingibitora APF (Perindoprila) i diuretika (Indapamida) - na razvitie serdechno-sosudistykh oslozhneniy u patsientov s sakharnym diabetom 2 tipa
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2008)

Cardiovascular diabetology
Publicado: (2002)

AP control of as the most efficacious tool for the prevention of cardiovascular complications in patients with type 2 diabetes mellitus
por: Yury Alexandrovich Karpov
Publicado: (2009)

Sequential Extraction, Characterization, and Analysis of Pumpkin Polysaccharides for Their Hypoglycemic Activities and Effects on Gut Microbiota in Mice
por: Hui-qing Wu, et al.
Publicado: (2021)